Reasoned opinion on the modification of the existing MRLs for bromuconazole in wheat and rye

In accordance with Article 6 of Regulation (EC) No 396/2005, Belgium, hereafter referred to as the evaluating Member State (EMS), received an application from Sumitomo Chemical Agro Europe S.A.S. to modify the existing maximum residue levels (MRLs) for the active substance bromuconazole in wheat and rye. In order to accommodate for the intended use of bromuconazole, Belgium proposed to raise the existing MRLs from the value of 0.2 mg/kg to 0.3 mg/kg. Belgium drafted an evaluation report in accordance with Article 8 of Regulation (EC) No 396/2005 which was submitted to the European Commission and forwarded to EFSA. According to EFSA the data are sufficient to derive MRL proposals of 0.2 mg/kg for the intended use on wheat and rye, which do not require a modification of the existing MRLs. An adequate analytical enforcement method is available to control the residues of bromuconazole in cereals. Based on the risk assessment results, EFSA concludes that the proposed use of bromuconazole on wheat and rye will not result in a consumer exposure exceeding the toxicological reference values of bromuconazole and therefore is unlikely to pose a consumer health risk related to this compound.